microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers

Oncology Reports

Volumn 30, Issue 1, 2013, Pages 320-326

  Vega, Anna Brunet ^a   Pericay, Carles ^a   Moya, Irene ^a   Ferrer, Anna ^b,c   Dotor, Emma ^a   Pisa, Aleydis ^a   Casalots, Àlex ^a   Serra Aracil, Xavier ^a   Oliva, Joan Carles ^a   Ruiz, Anna ^a   Saigí, Eugeni ^a  

^a Hospital Universitari Parc Taulí   (Spain)

^b CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Colorectal cancer; microRNA; Serum biomarker

Indexed keywords

FORMALDEHYDE; MICRORNA; MICRORNA 141; MICRORNA 20A; MICRORNA 21; MICRORNA 29A; MICRORNA 31; MICRORNA 34A; PARAFFIN; PROTEIN MIR 135B; PROTEIN MIR 18A; PROTEIN MIR 224; PROTEIN MIR 29A; PROTEIN MIR 92A; PROTEIN MIR 96; SMALL UNTRANSLATED RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

AGED; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84878190315     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2475     Document Type: Article

References (31)

1. Weitz J, Koch M, Debus J, Höhler T, Galle PR and Büchler MW: Colorectal cancer. Lancet 365: 153-165, 2005. (Pubitemid 40091806)
2. O'Connell JB, Maggard MA and Ko CY: Colon cancer survival rates with the new American Joint Committee on Cancer 6th edition staging. J Natl Cancer Inst 96: 1420-1425, 2004. (Pubitemid 39429665)
3. No authors listed: Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol 17: 1356-1363, 1999.
4. No authors listed: Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet 345: 939-944, 1995.
5. Wu H, Neilson JR, Kumar P, et al: miRNA profiling of naïve, effector and memory CD8 T cells. PLoS One 2: e1020, 2007.
6. Wiemer EA: The role of microRNAs in cancer: no small matter. Eur J Cancer 43: 1529-1544, 2007.
7. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006. (Pubitemid 44629897)
8. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
9. Michael MZ, O' Connor SM, van Holst Pellekaan NG, Young GP and James RJ: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891, 2003. (Pubitemid 37288707)
10. Cummins JM, He Y, Leary RJ, et al: The colorectal microRNAome. Proc Natl Acad Sci USA 103: 3687-3692, 2006. (Pubitemid 43376616)
11. Bandrés E, Cubedo E, Agirre X, et al: Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29, 2006.
12. Garzon R, Calin GA and Croce CM: MicroRNAs in cancer. Annu Rev Med 60: 167-179, 2009.
13. Ma J, Dong C and Ji C: MicroRNA and drug resistance. Cancer Gene Ther 17: 523-531, 2010.
14. Hurst DR, Edmonds MD and Welch DR: Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 69: 7495-7498, 2009.
15. Zhang H, Li Y and Lai M: The microRNA network and tumor metastasis. Oncogene 29: 937-948, 2010.
16. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
17. Weber JA, Baxter DH, Zhang S, et al: The microRNA spectrum in 12 body fluids. Clin Chem 56: 1733-1741, 2010.
18. Chen X, Ba Y, Ma L, et al: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006, 2008.
19. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659, 2007. (Pubitemid 47214727)
20. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y and Ochiya T: Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285: 17442-17452, 2010.
21. Ritchie ME, Silver J, Oshlack A, et al: A comparison of background correction methods for two-colour microarrays. Bioinformatics 23: 2700-2707, 2007. (Pubitemid 350048334)
22. Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article 3, 2004.
23. Gentleman RC, Carey VJ, Bates DM, et al: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80, 2004.
24. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108, 2008. (Pubitemid 351818697)
25. Benjamini Y, Drai D, Elmer G, Kafkafi N and Golani I: Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284, 2001. (Pubitemid 33000466)
26. Ng EK, Chong WW, Jin H, et al: Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381, 2009.
27. Huang Z, Huang D, Ni S, Peng Z, Sheng W and Du X: Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118-126, 2010.
28. Tsang WP and Kwok TT: The miR-18a*microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis 30: 953-959, 2009.
29. Morimura R, Komatsu S, Ichikawa D, et al: Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br J Cancer 105: 1733-1740, 2011.
30. Weissmann-Brenner A, Kushnir M, Lithwick Yanai G, et al: Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer. Int J Oncol 40: 2097-2103, 2012.
31. Wang LG and Gu J: Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol 36: e61-e67, 2012.